INTERSTITIAL LUNG DISEASE: RETROSPECTIVE STUDY OF THE PROGNOSTIC IMPACT OF ACUTE EXACERBATIONS

被引:0
|
作者
Pacheco, Joana M. [1 ]
Santos, Ana I. [1 ]
Catarata, Joana [2 ]
Freitas, Sara [1 ]
机构
[1] Coimbra Hosp & Univ Ctr, Pulmonol Dept, Mota Pinto,3004-56, Coimbra, Portugal
[2] Braga Hosp, Pulmonol Dept, Braga, Portugal
关键词
KEY WORDS: interstitial lung disease; pulmonary fibrosis; acute exacerbation;
D O I
10.36141/svdld.v41i4.15198
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Interstitial lung diseases have high mortality associated with hospitalization for decompensation. There are doubts about the factors involved in the progression of fibrosis, for example the role played by acute exacerbations. With this work, the authors intend to analyze whether there are predictive parameters of mortality related to exacerbations. Methods: A retrospective study was carried out of patients admitted to the Pulmonology department of Coimbra University Hospital Center for exacerbation of fibrosing lung disease between January 2019 and December 2020. These were classified as: idiopathic pulmonary fibrosis (IPF), fibrosing hypersensivity pneumonitis (FHP) and other fibrosing lung diseases. Statistical analysis was performed using SPSS 26.0 considering statistically significant p<0.05 values. Results: The results show that IPF is associated with longer hospital stay in relation to fibrosing HP and other fibrosing lung diseases mean of 20.93 days (95% CI: 14.69-27.18) vs 11.8 days (95% CI: 1.05-17.22, p=0.023) vs 12.23 days (95% CI: 2.06-15.34, p=0.007), respectively. Regarding mortality, there was no difference between IPF, PH and other fibrosing diseases (p=0.631). Conclusion: This study demonstrated that IPF, compared to PH and other fibrosing diseases, is associated with longer hospital stays, probably due to its progressive course despite the institution of corticosteroid therapy. As shown in previous studies, it was concluded that there is no difference in terms of mortality between IPF exacerbations and other forms of fibrosing lung disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single-center, retrospective cohort study
    Hyun, Dong-gon
    Han, Soo Jin
    Ji, Wonjun
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Ho Cheol
    THORACIC CANCER, 2023, 14 (33) : 3323 - 3330
  • [2] Treatment of acute exacerbations of interstitial lung disease
    Azadeh, Natalya
    Moua, Teng
    Baqir, Misbah
    Ryu, Jay H.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (04) : 309 - 313
  • [3] Acute exacerbations complicating interstitial lung disease
    Ryerson, Christopher J.
    Collard, Harold R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (05) : 436 - 441
  • [4] Acute exacerbations of fibrotic interstitial lung disease
    Churg, Andrew
    Wright, Joanne L.
    Tazelaar, Henry D.
    HISTOPATHOLOGY, 2011, 58 (04) : 525 - 530
  • [5] Acute exacerbations in children's interstitial lung disease
    Seidl, Elias
    Schwerk, Nicolaus
    Carlens, Julia
    Wetzke, Martin
    Emiralioglu, Nagehan
    Kiper, Nural
    Lange, Joanna
    Krenke, Katarzyna
    Szepfalusi, Zsolt
    Stehling, Florian
    Baden, Winfried
    Haemmerling, Susanne
    Jerkic, Silvija-Pera
    Proesmans, Marijke
    Ullmann, Nicola
    Buchvald, Frederik
    Knoflach, Katrin
    Kappler, Matthias
    Griese, Matthias
    THORAX, 2022, 77 (08) : 799 - 804
  • [6] Risk Assessment for Acute Exacerbations of Interstitial Lung Disease
    Dinparastisaleh, R.
    Boppana, L.
    Shahraki, A. Hashemi
    Najjar, N.
    Mirsaeidi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] Management of Acute Interstitial Lung Disease Exacerbations and Transplant Outcomes
    Chizinga, M.
    Patel, D. C.
    Alzghoul, B. N.
    Lin, C. M.
    Scheuble, V.
    Mehrad, B.
    Pelaez, A.
    Manjarres, D. C. Gomez
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] ACUTE EXACERBATIONS OF INTERSTITIAL LUNG DISEASE: WHAT IS THE BEST TREATMENT?
    Meyer, Keith C.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2021, 38 (01)
  • [9] Steroid Therapy in Acute Exacerbations of Fibrotic Interstitial Lung Disease
    Koshy, K.
    Barnes, H.
    Thien, F.
    Glaspole, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] Clinical Implications of Frailty in Acute Exacerbations of Interstitial Lung Disease
    Chohan, K.
    Adams, C. J.
    Fisher, J. H.
    Shapera, S.
    Fidler, L.
    Kavanagh, J.
    Reid, W.
    Goligher, E. C.
    Martinu, T.
    Wickerson, L.
    Mathur, S.
    Singer, L. G.
    Rozenberg, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201